Trial Profile

Effect of the angiotensin II receptor antagonist irbesartan on insulin sensitivity and metabolic profile in patients with chronic heart failure

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Mar 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Irbesartan (Primary)
Indications Chronic heart failure
Focus Biomarker; Pharmacodynamics
Acronyms IRIS-HF

Most Recent Events

31 Mar 2009 Results were presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC-2009).
30 Aug 2008 Results were presented at ESC Congress 2008: Annual Congress of the European Society of Cardiology.
30 Oct 2007 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com